Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 1 - 20 results of 4,752 for search '(( significant clinical decrease ) OR ( significant ((side decrease) OR (nn decrease)) ))', query time: 0.37s Refine Results
  1. 1
    Inotodiol decreases clone formation in HCC cells.

    Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

    Published 2025
    “…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
    Save to List
    Saved in:
  2. 2
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

    Published 2025
    “…Additionally, the plots on the right side display the average plaque count across the cohorts. …”
    Save to List
    Saved in:
  4. 4
    Fig 1 -

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Fig 8 -

    Fig 8 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells.

    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Fig 4 -

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Fig 9 -

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Trypan blue dye exclusion assay for cell viability evaluation (% of control).

    Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Fig 7 -

    Fig 7 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Fig 10 -

    Fig 10 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Fig 5 -

    Fig 5 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Fig 6 -

    Fig 6 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    <i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model.

    <i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT.

    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and heart rate (HR) across the three conditions.

    Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side.

    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 20
    Basic characteristics of the studies included.

    Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: